Overview

Phase 3 Clinical Trial of Teriparatide in Japan

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of teriparatide based on measurements of bone mineral density at lumbar spine
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Teriparatide